STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Claritev Corp Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Claritev Corp (CTEV) president, CEO, executive chair and director reported a personal-related purchase of Class A common stock. On 11/20/2025, the reporting person acquired 5,290 shares at a weighted average price of $47.2291 per share through the spouse's individual retirement account, which is reported as indirect ownership. After this transaction, indirect holdings in that account totaled 9,572 Class A shares, while direct ownership was reported as 243,058 Class A shares. The price range for the purchases on that date was from $47.0000 to $47.2300 per share.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dalton Travis

(Last) (First) (Middle)
C/O CLARITEV CORPORATION
7900 TYSONS ONE PLACE, SUITE 400

(Street)
MCLEAN VA 22102

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Claritev Corp [ CTEV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Pres., CEO & Executive Chair
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A common stock 11/20/2025 P 5,290 A $47.2291(1) 9,572 I Spouse's Individual Retirement Account
Class A common stock 243,058 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $47.0000 to $47.2300, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4.
Remarks:
/s/ Kent Bartholomew, attorney-in-fact 11/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Claritev Corp (CTEV) report on this Form 4?

The filing reports that a Claritev Corp insider purchased 5,290 shares of Class A common stock on 11/20/2025 through the spouse's individual retirement account.

At what price were the Claritev Corp (CTEV) shares purchased?

The 5,290 Class A common shares were bought at a weighted average price of $47.2291 per share, with individual trades ranging from $47.0000 to $47.2300.

What is the insider's total indirect ownership in Claritev Corp (CTEV) after the transaction?

Following the reported transaction, the insider's indirect ownership via the spouse's individual retirement account was 9,572 Class A common shares.

How many Claritev Corp (CTEV) shares does the insider directly own after this filing?

The filing shows direct ownership of 243,058 Class A common shares after the reported transaction.

What is the insider's role at Claritev Corp (CTEV)?

The reporting person is identified as a director and an officer, serving as president, CEO and executive chair of Claritev Corp.

Was this Claritev Corp (CTEV) trade executed under a Rule 10b5-1 plan?

The form includes a checkbox to indicate transactions made under a Rule 10b5-1 plan, but the excerpt does not show that box as marked for this transaction.
Claritev Corp

NYSE:CTEV

CTEV Rankings

CTEV Latest News

CTEV Latest SEC Filings

CTEV Stock Data

747.45M
9.13M
6.66%
87.06%
4.15%
Health Information Services
Services-business Services, Nec
Link
United States
MCLEAN